Showing 1 - 20 results of 44 for search 'Isabel Spriet', query time: 0.07s
Refine Results
-
1
Guidance for Demonstrating the Societal Value of new Antibiotics by Steven Simoens, Isabel Spriet, Isabel Spriet
Published 2021-02-01
Article -
2
Editorial: Women in pharmacology of infectious diseases: 2021 by Elena K. Schneider-Futschik, Isabel Spriet, Hong Zhou
Published 2022-10-01
Article -
3
-
4
-
5
Software Tools for Model-Informed Precision Dosing: How Well Do They Satisfy the Needs? by Wannee Kantasiripitak, Ruth Van Daele, Ruth Van Daele, Matthias Gijsen, Matthias Gijsen, Marc Ferrante, Marc Ferrante, Isabel Spriet, Isabel Spriet, Erwin Dreesen, Erwin Dreesen
Published 2020-05-01
Article -
6
Interaction between posaconazole and flucloxacillin in a lung transplant patient: decrease in plasma exposure of posaconazole and possible undertreatment of invasive aspergillosis:... by Saartje Verfaillie, Laurent Godinas, Isabel Spriet, Robin Vos, Geert M. Verleden
Published 2022-03-01
Article -
7
Increasing Incidence of Mucormycosis in University Hospital, Belgium by Veroniek Saegeman, Johan Maertens, Wouter Meersseman, Isabel Spriet, Eric Verbeken, Katrien Lagrou
Published 2010-09-01
Article -
8
-
9
Casus over hepatotoxiciteit door atorvastatine: de zoektocht naar mogelijke etiologie by Anne Castermans, Julie Hias, Lorenz Van der Linden, Isabel Spriet, Jos Tournoy
Published 2022-08-01
Article -
10
-
11
Correction: Review of the novel antifungal drug olorofim (F901318) by Yuri Vanbiervliet, Tine Van Nieuwenhuyse, Robina Aerts, Katrien Lagrou, Isabel Spriet, Johan Maertens
Published 2024-12-01
Article -
12
Review of the novel antifungal drug olorofim (F901318) by Yuri Vanbiervliet, Tine Van Nieuwenhuyse, Robina Aerts, Katrien Lagrou, Isabel Spriet, Johan Maertens
Published 2024-11-01
Article -
13
Meropenem Pharmacokinetics and Target Attainment in Critically Ill Patients Are Not Affected by Extracorporeal Membrane Oxygenation: A Matched Cohort Analysis by Matthias Gijsen, Erwin Dreesen, Pieter Annaert, Johan Nicolai, Yves Debaveye, Joost Wauters, Isabel Spriet
Published 2021-06-01
Article -
14
-
15
Pharmacokinetic/Pharmacodynamic Target Attainment Based on Measured versus Predicted Unbound Ceftriaxone Concentrations in Critically Ill Patients with Pneumonia: An Observational... by Matthias Gijsen, Erwin Dreesen, Ruth Van Daele, Pieter Annaert, Yves Debaveye, Joost Wauters, Isabel Spriet
Published 2021-05-01
Article -
16
Saliva for Precision Dosing of Antifungal Drugs: Saliva Population PK Model for Voriconazole Based on a Systematic Review. by Hannah Yejin Kim, Hannah Yejin Kim, Hannah Yejin Kim, Anne-Grete Märtson, Erwin Dreesen, Isabel Spriet, Isabel Spriet, Sebastian G. Wicha, Andrew J. McLachlan, Jan-Willem Alffenaar, Jan-Willem Alffenaar, Jan-Willem Alffenaar
Published 2020-06-01
Article -
17
Medication review versus usual care to improve drug therapies in older inpatients not admitted to geriatric wards: a quasi-experimental study (RASP-IGCT) by Lorenz Van der Linden, Julie Hias, Lisa Dreessen, Koen Milisen, Johan Flamaing, Isabel Spriet, Jos Tournoy
Published 2018-07-01
Article -
18
Reproducibility of fluid status measured by bioelectrical impedance analysis in healthy volunteers: a key requirement to monitor fluid status in the intensive care unit by Matthias Gijsen, Eline Simons, Pieter De Cock, Manu L.N.G. Malbrain, Joost Wauters, Isabel Spriet
Published 2021-05-01
Article -
19
-
20